Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model()()

por Shi, Shengbin, Rao, Quan, Zhang, Chuangnian, Zhang, Xiuyuan, Qin, Yibo, Niu, Zuoxing
Publicado 2018

SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand or gemcitabine

por ZHOU, WUYUAN, SHI, JUN, NIU, ZUOXING, LUO, HONGMIN, TIAN, HE, GAO, JIE, YU, FACHANG, LI, SHENG
Publicado 2013

Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional p...

por Wang, Fenghua, Dai, Guanghai, Deng, Yanhong, Tang, Yong, Wang, Wei, Niu, Zuoxing, Bi, Feng, Zhu, Liangjun, Guo, Zengqing, Yan, Jin, Hu, Bing, Tao, Min, Yang, Shujun, Zhang, Suzhan, Wen, Lu, Xu, Ruihua
Publicado 2021

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

por Wu, Jianqiu, Song, Yongping, Su, Liping, Xu, Li, Chen, Tingchao, Zhao, Zhiyun, Zhang, Mingzhi, Li, Wei, Hu, Yu, Zhang, Xiaohong, Gao, Yuhuan, Niu, Zuoxing, Feng, Ru, Wang, Wei, Peng, Jiewen, Li, Xiaolin, Ouyang, Xuenong, Wu, Changping, Zhang, Weijing, Zeng, Yun, Xiao, Zhen, Liang, Yingmin, Zhuang, Yongzhi, Wang, Jishi, Sun, Zimin, Bai, Hai, Cui, Tongjian, Feng, Jifeng
Publicado 2016

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

por Shen, Lin, Kato, Ken, Kim, Sung-Bae, Ajani, Jaffer A., Zhao, Kuaile, He, Zhiyong, Yu, Xinmin, Shu, Yongqian, Luo, Qi, Wang, Jufeng, Chen, Zhendong, Niu, Zuoxing, Zhang, Longzhen, Yi, Tienan, Sun, Jong-Mu, Chen, Jianhua, Yu, Guohua, Lin, Chen-Yuan, Hara, Hiroki, Bi, Qing, Satoh, Taroh, Pazo-Cid, Roberto, Arkenau, Hendrick-Tobias, Borg, Christophe, Lordick, Florian, Li, Liyun, Ding, Ningning, Tao, Aiyang, Shi, Jingwen, Van Cutsem, Eric
Publicado 2022

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Commi...

por Ba, Yi, Shi, Yuankai, Jiang, Wenqi, Feng, Jifeng, Cheng, Ying, Xiao, Li, Zhang, Qingyuan, Qiu, Wensheng, Xu, Binghe, Xu, Ruihua, Shen, Bo, Luo, Zhiguo, Xie, Xiaodong, Chang, Jianhua, Wang, Mengzhao, Li, Yufu, Shuang, Yuerong, Niu, Zuoxing, Liu, Bo, Zhang, Jun, Zhang, Li, Yao, Herui, Xie, Conghua, Huang, Huiqiang, Liao, Wangjun, Chen, Gongyan, Zhang, Xiaotian, An, Hanxiang, Deng, Yanhong, Gong, Ping, Xiong, Jianping, Yao, Qinghua, An, Xin, Chen, Cheng, Shi, Yanxia, Wang, Jialei, Wang, Xiaohua, Wang, Zhiqiang, Xing, Puyuan, Yang, Sheng, Zhou, Chenfei
Publicado 2020

Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)

por Yang, Yu, Sun, Juxian, Wu, Mengchao, Lau, Wan Yee, Zheng, Shusen, Wang, Xue-Hao, Chen, Xiaoping, Fan, Jia, Dong, Jiahong, Cai, Jianqiang, Chen, Minshan, Chen, Yongjun, Cheng, Zhangjun, Dai, Chaoliu, Shan, Jianzhen, Du, Cheng-You, Fang, Chihua, Hu, Heping, Ji, Zhili, Jia, Weidong, Li, Gong, Li, Jing, Li, Jiangtao, Liu, Chang, Liu, Fubao, Ma, Yong, Mao, Yilei, Niu, Zuoxing, Shen, Jie, Shi, Jie, Shi, Xuetao, Song, Wenjie, Sun, Hui-Chuan, Tan, Guang, Tao, Ran, Wang, Xiaohu, Wen, Tianfu, Wu, Liqun, Xia, Jinglin, Xiang, Bang-De, Yan, Maolin, Ying, Mingang, Zhang, Ling, Zhang, Xuewen, Zeng, Zhao Chong, Zhang, Yubao, Zhang, Zhiwei, Zhou, Jie, Zhou, Cuncai, Zhou, Jun, Zhou, Ledu, Zhou, Xinmin, Zhu, Ji, Zhu, Zhenyu, Zhang, Qi, Li, Qiu, Cheng, Shuqun
Publicado 2022